title: Induction of sarcomas by a single subcutaneous injection of 7,12-dimethylbenz[a]anthracene into neonatal male Sprague-Dawley rats: histopathological and immunohistochemical analyses.
abstract: Animal experiments have shown that carcinogenicity of chemicals is higher in fetal or neonatal periods than adult. We investigated sensitivities to a carcinogen in peri-neonatal rats with a model of sarcomas-induction by a subcutaneous injection of chemo-carcinogen that has rarely done in neonatal rats. Neonatal male SD rats were injected with 7,12-DMBA 10, 100, and 500 microg, which resulted in sarcomas-induction in 0, 62, and 94% of rats. Male SD rats were injected with DMBA 500 microg at 0, 3, 7, 14, and 21 days, which resulted in sarcomas-induction in 94, 70, 64, 50, and 44% of rats. Although the induced sarcomas were occasionally in mixed morphological feature as previous reports for sarcomas of rat, each was immunohistochemically in almost monotonous pattern, and classification was feasible. The incidence of rhabdomyosarcomas was higher in rats neonatally injected with a higher dose of DMBA than a lower dose, and in rats injected at peri-neonatal periods than later periods. In histological observations for the site of injection before overt sarcomas develop, clusters of atypical mesenchymal cells emerged as previous studies, but also those were immunohistochemically differentiated into rhabdomyocytes and other mesenchymal cells. We consider these findings may contribute a little to elucidation of process of sarcomas-induction in rats.
authors.affiliation: Department of Tumor Pathology, Field of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, 890-8520, Japan.
authors.forename: Shuuhei
authors.initials: S
authors.lastname: Taguchi
authors.forename: Kazumi
authors.initials: K
authors.lastname: Kuriwaki
authors.forename: Masakazu
authors.initials: M
authors.lastname: Souda
authors.forename: Mamoru
authors.initials: M
authors.lastname: Funato
authors.forename: Kenjiro
authors.initials: K
authors.lastname: Ninomiya
authors.forename: Yoshihisa
authors.initials: Y
authors.lastname: Umekita
authors.forename: Hiroki
authors.initials: H
authors.lastname: Yoshida
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene / Q000008:administration & dosage / Q000633:toxicity*; D000818:Animals; D000831:Animals, Newborn; D002273:Carcinogens / Q000008:administration & dosage / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D007150:Immunohistochemistry; D015994:Incidence; D007279:Injections, Subcutaneous; D008297:Male; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000145:classification / Q000453:epidemiology / Q000378:metabolism* / Q000473:pathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012509:Sarcoma / Q000139:chemically induced / Q000145:classification / Q000453:epidemiology / Q000378:metabolism* / Q000473:pathology*; D013997:Time Factors
chemical_list: D002273:Carcinogens; D015127:9,10-Dimethyl-1,2-benzanthracene